Total Body Irradiation vs Term Birth Living Child

Dosing and Administration of drugs: it is recommended to take oral food, grrr Dyspepsia - adults 10 mg 3 g / day for 15 - 30 minutes before meals and, if necessary, before bedtime, if necessary referred to the dose can be doubled; MDD - 2,4 mg / kg body weight, but not more than 80 mg g and subacute states (nausea and vomiting) - adults 20 mg 3 here 4 g copy-book day before meals and at bedtime, children older 12 - 1 or 2 tab. chewing on 80 mg, 125 mg. Indications medicine: nausea and vomiting of various origins (due to anesthesia, radiation and chemotherapy, toxemia, migraine, CCT copy-book diet), gastrointestinal tract dysmotility in functional dyspepsia, reflux esophagitis, duodenitis peptic ulcer, diabetic hastroparezi, postoperative gastric atony; used to facilitate sensing or Studies of radio-opaque alimentary canal. of 0,01 g; Table. Method of production of drugs: Table. instant 10 mg. Indications for use drugs: nausea, vomiting, dyspeptic symptoms complex, resulting from slowing emptying stomach, GERD, esophagitis (feeling full stomach, bloating and epigastric pain, belching, flatulence, heartburn); nausea and vomiting, functional or organic origin (including infections, diet disorders, treatment or radiation therapy), nausea and vomiting caused by antagonists copy-book dopamine (levodopa and bromokryptyn). Method of production of drugs: for oral suspension, 40 mg whole body radiation ml to 50 ml or 75 ml or 100 ml, and 66.6 mg / ml 30 ml in vials; Crapo. Method of production of drugs: Table., Film-coated, 10 mg tab. 10 mg 3 - 4 g / day for 15 - 30 minutes before meals, if necessary, before going to sleep but not more than 80 mg / day, children from 5 to 12 years - 0,25-0,5 mg / kg 3 - 4 g / day for 15 - 30 minutes before meals. Contraindications to the use of drugs: hypersensitivity to the drug, gastrointestinal bleeding, intestinal obstruction, gastrointestinal tract perforation, pigment and prolaktonozalezhni tumors, phaeochromocytoma, epilepsy, glaucoma, extrapyramidal disorders, and trimester of pregnancy, lactation and children under 2 years. Pharmacotherapeutic group: A03FA01 - stimulants peristalsis (propulsanty).